Justice Dept.: Chief Science Officer of Publicly Traded Health Care Company Charged for Insider Trading Scheme Utilizing 10b5-1 Trading Plans
December 24, 2024
December 24, 2024
WASHINGTON, Dec. 24 -- The U.S. Department of Justice issued the following news release on Dec. 23, 2024:
* * *
Second Indictment Stemming from Fraud Section's Data-Driven Initiative to Identify 10b5-1 Trading Plan Abuses
* * *
An indictment was unsealed today charging a former U.S. citizen with engaging in an insider trading scheme involving the stock of Humanigen Inc., a publicly traded biopharmaceutical company. Dale Chappell, 54, who w . . .
* * *
Second Indictment Stemming from Fraud Section's Data-Driven Initiative to Identify 10b5-1 Trading Plan Abuses
* * *
An indictment was unsealed today charging a former U.S. citizen with engaging in an insider trading scheme involving the stock of Humanigen Inc., a publicly traded biopharmaceutical company. Dale Chappell, 54, who w . . .